Location History:
- Copenhagen, DK (1991 - 1992)
- Roskilde, DK (1992 - 1995)
Company Filing History:
Years Active: 1991-1995
Title: Innovations by Finn B Hansen in Insulin Compounds
Introduction
Finn B Hansen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of insulin compounds. With a total of 4 patents to his name, Hansen's work has had a profound impact on diabetes treatment.
Latest Patents
Hansen's latest patents focus on novel insulin compounds and compositions. These compounds are designed to have a protracted insulin action and reduced antigenicity. The innovative insulin compounds are represented by a specific formula, which includes various amino acid residues that can be coded for by nucleotide sequences. Additionally, he has developed insulin derivatives and pharmaceutical preparations that contain these derivatives. These preparations are characterized by their protracted insulin activity, which is relatively insensitive to tryptic activity.
Career Highlights
Throughout his career, Finn B Hansen has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S. His expertise in insulin research has positioned him as a key figure in the development of advanced diabetes treatments.
Collaborations
Hansen has collaborated with various professionals in his field, including his coworker Per Balschmidt. Their joint efforts have contributed to the advancement of insulin therapies.
Conclusion
Finn B Hansen's innovative work in insulin compounds has paved the way for improved diabetes management. His contributions continue to influence the pharmaceutical landscape, showcasing the importance of research and development in healthcare.